CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
antihypertensive agents +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000487
NCT00000487Phase 3Completed
CompareCT.gov

Multiple Risk Factor Intervention Trial for the Prevention of Coronary Heart Disease (MRFIT)

University of Minnesota·interventional·Posted Oct 28, 1999·Updated Feb 25, 2016

In Brief

A Phase 3 clinical trial evaluating antihypertensive agents, smoking cessation, and 2 other interventions for Cardiovascular Diseases and 3 related conditions. Completed.

Detailed Summary

To determine for a group of men at high risk of death from coronary heart disease whether a special intervention program to lower serum cholesterol, reduce blood pressure, and eliminate cigarette smoking would result in a significant reduction in mortality from coronary heart disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Ischemia
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
1971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
First PostedOct 28, 1999
Enrollment StartJun 1, 1972
Study CompletionJul 1, 1998
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

antihypertensive agentsdrug

smoking cessationbehavioral

diet, fat-restrictedbehavioral

diureticsdrug